Table 1. Baseline characteristics.
CAD+ |
CAD− |
||
---|---|---|---|
n=482 | n=1212 | P-value | |
Age first visit lipid clinic (years) | 50.5 (11.1) | 42.2 (12.3) | <0.0001 |
Age last visit lipid clinic (years) | 57.1 (11.2) | 46.6 (12.5) | <0.0001 |
Male gender | 301 (62) | 516 (42) | <0.0001 |
Diabetes mellitus | 54 (11) | 45 (4) | <0.0001 |
Hypertension | 79 (16) | 77 (6) | <0.0001 |
History of smoking | 365 (75) | 766 (63) | <0.0001 |
Body mass index, kg/m2 | 25.7±3.2 | 24.9±3.6 | <0.0001 |
Family history CVD | 204 (42) | 607 (50) | 0.005 |
Treatment-naive lipids levels: | |||
Total cholesterol, mmol/l | 9.6 (2.1) | 9.4 (1.9) | 0.146 |
LDL-cholesterol, mmol/l | 7.0 (1.9) | 7.2 (1.8) | 0.152 |
HDL-cholesterol, mmol/l | 1.1 (0.3) | 1.2 (0.4) | <0.0001 |
Triglyceridesa, mmol/l | 1.8 (1.3–2.5) | 1.5 (1.0–2.0) | <0.0001 |
LDL-receptor mutation provenb | 207 (43) | 655 (54) | 0.017 |
Age of CAD onset, years | 49.1±10.7 | Na | Na |
Age of start statin use | 48.8±11.5 | 40.9±12.6 | <0.0001 |
Abbreviations: CAD, coronary artery disease; CVD, cardiovascular disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Values are given as number (percentage) or mean±SD unless indicated otherwise.
Mean±interquartile range.
Mutations of the LDL receptor that have been examined according to Umans-Eckenhausen MA et al.13